Abstract
Corticosteroids are the most effective treatment for asthma but the therapeutic response varies markedly between individuals. Multiple factors including genetic, environmental, asthma related and concordance are likely to contribute to the heterogeneous response to corticosteroids. Genetic variations at the level of the glucocorticoid receptor have not been implicated to date, but polymorphisms of TBX21 and corticotrophin-releasing hormone receptor 1 genes are associated with enhanced efficacy to inhaled corticosteroids. Cigarette smoking is an important cause of insensitivity to corticosteroids. Mechanisms of corticosteroid insensitivity in smokers with asthma are currently unexplained, but could be due to alterations in airway inflammatory cell phenotypes, changes in glucocorticoid receptor α to β ratio, and/or reduced histone deacetylase activity. Exposure to allergens, infections and neutrophilic airway inflammation as well as race and the rare phenotype of corticosteroid resistant asthma are implicated in reduced efficacy. Poor concordance with treatment is of particular importance. Management involves advice on smoking cessation for smokers, assessment of concordance and inhaler technique, review of delivery of care and step up in treatment only after these issues have been addressed. In the future, corticosteroid treatment might be guided by pharmacogenetic assays and the use of alternative or additional drugs for specific corticosteroid insensitive groups such as smokers with asthma.
Keywords: Corticosteroids, corticosteroid insensitivity, smoking, asthma, pharmacogenetics, concordance
Current Respiratory Medicine Reviews
Title: Factors Influencing Individual Variability in the Therapeutic Response to Corticosteroids in Asthma
Volume: 2 Issue: 2
Author(s): Mark Spears and Neil C. Thomson
Affiliation:
Keywords: Corticosteroids, corticosteroid insensitivity, smoking, asthma, pharmacogenetics, concordance
Abstract: Corticosteroids are the most effective treatment for asthma but the therapeutic response varies markedly between individuals. Multiple factors including genetic, environmental, asthma related and concordance are likely to contribute to the heterogeneous response to corticosteroids. Genetic variations at the level of the glucocorticoid receptor have not been implicated to date, but polymorphisms of TBX21 and corticotrophin-releasing hormone receptor 1 genes are associated with enhanced efficacy to inhaled corticosteroids. Cigarette smoking is an important cause of insensitivity to corticosteroids. Mechanisms of corticosteroid insensitivity in smokers with asthma are currently unexplained, but could be due to alterations in airway inflammatory cell phenotypes, changes in glucocorticoid receptor α to β ratio, and/or reduced histone deacetylase activity. Exposure to allergens, infections and neutrophilic airway inflammation as well as race and the rare phenotype of corticosteroid resistant asthma are implicated in reduced efficacy. Poor concordance with treatment is of particular importance. Management involves advice on smoking cessation for smokers, assessment of concordance and inhaler technique, review of delivery of care and step up in treatment only after these issues have been addressed. In the future, corticosteroid treatment might be guided by pharmacogenetic assays and the use of alternative or additional drugs for specific corticosteroid insensitive groups such as smokers with asthma.
Export Options
About this article
Cite this article as:
Spears Mark and Thomson C. Neil, Factors Influencing Individual Variability in the Therapeutic Response to Corticosteroids in Asthma, Current Respiratory Medicine Reviews 2006; 2 (2) . https://dx.doi.org/10.2174/157339806776843102
DOI https://dx.doi.org/10.2174/157339806776843102 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Data Analysis-Driven Precise Asthmatic Treatment by Targeting Mast Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Free Fatty Acid Receptors as New Potential Targets in Colorectal Cancer
Current Drug Targets Mono- and Bis-2-amino-4H-pyrans: Alum Catalyzed Three- or Pseudo Five-Component Reaction of 4-Hydroxycoumarin, Malononitrile and Aldehydes
Letters in Organic Chemistry Low Molecular Weight Compounds with Transition Metals as Free Radical Scavengers and Novel Therapeutic Agents
Cardiovascular & Hematological Agents in Medicinal Chemistry Thymic Immunosuppressive Pentapeptide (TIPP) Shown Anticancer Activity in Breast Cancer and Chronic Myeloid Leukemia Both <i>In Vitro</i> and <i>In Vivo</i>
Protein & Peptide Letters Design of Broad-Spectrum Inhibitors of Influenza A Virus M2 Proton Channels: A Molecular Modeling Approach
Current Computer-Aided Drug Design Biomarker Metabolite Signatures Pave the Way for Electronic-nose Applications in Early Clinical Disease Diagnoses
Current Metabolomics SARS-CoV-2 Transmission Among Healthcare Workers in Iran: An Urgent Need for Early Identification and Management
Infectious Disorders - Drug Targets Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's Disease
Current Neuropharmacology Dendritic Cells for Active Anti-Cancer Immunotherapy: Targeting Activation Pathways Through Genetic Modification
Endocrine, Metabolic & Immune Disorders - Drug Targets Transcription Factors as Targets for Cancer Therapy: AP-1 a Potential Therapeutic Target
Current Cancer Therapy Reviews Novel Nor-Homo- and Spiro-Oxetan- Steroids Target the Human Androgen Receptor and Act as Antiandrogens
Current Medicinal Chemistry HLA and TCR Recognition of Medications in Severe Cutaneous Adverse Reactions
Current Immunology Reviews (Discontinued) Small Molecule Inhibitors of Phosphoinositide 3-Kinase (PI3K) δ and γ
Current Topics in Medicinal Chemistry Update on Clinical, Pathophysiological and Therapeutic Aspects in ANCAAssociated Vasculitides
Current Drug Discovery Technologies p38 MAPK: A Potential Target of Chronic Pain
Current Medicinal Chemistry Depression in Sleep Related Breathing Disorder
Current Respiratory Medicine Reviews Association between the Use of Inhaled Corticosteroids and Pulmonary Nontuberculous Mycobacterial Infection: A Systematic Review
Current Respiratory Medicine Reviews Signal Transduction Pathways of Inflammatory Gene Expressions and Therapeutic Implications
Current Pharmaceutical Design Basophil Activation Test with Indomethacin to Assess Hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs: A Preliminary Study
Inflammation & Allergy - Drug Targets (Discontinued)